Lenalidomide maintenance treatment after imatinib discontinuation: results of a phase 1 clinical trial in chronic myeloid leukaemia

DM Ross; IS Pagani; YD Irani; J Clarson; T Leclercq; P Dang; J McLean; VA Saunders; L Carne; J Reynolds; DS Ritchie; DL White; S Branford; TP Hughes; ASM Yong

Journal article

Lenalidomide maintenance treatment after imatinib discontinuation: results of a phase 1 clinical trial in chronic myeloid leukaemia

DM Ross, IS Pagani, YD Irani, J Clarson, T Leclercq, P Dang, J McLean, VA Saunders, L Carne, J Reynolds, DS Ritchie, DL White, S Branford, TP Hughes, ASM Yong

British Journal of Haematology | WILEY | Published : 2019

DOI: 10.1111/bjh.15894

Download PDF

University of Melbourne Researchers

David Ritchie Author

Grants

Awarded by Celgene

Funding Acknowledgements

This study was sponsored by the South Australian Health and Medical Research Institute (SAHMRI), and funded by research grants from Celgene and the National Health & Medical Research Council of Australia (APP1138935) to SAHMRI. The authors are grateful to the patients who participated in this study, and to Liddy Griffith and Juanita Ottaway of SAHMRI Clinical Research.